272
Participants
Start Date
July 31, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
TA-7284 Low
The patients will receive TA-7284-Low orally for 24 weeks.
TA-7284 High
The patients will receive TA-7284-High orally for 24 weeks.
Placebo
The patients will receive Placebo orally for 24 weeks.
Reserch site, Chūbu
Reserch site, Kanto
Reserch site, Kinki
Reserch site, Shikoku
Reserch site, Tōhoku
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
INDUSTRY